Video Experimental Relacionado

Updated: Jun 14, 2026

Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata
07:58

Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata

Published on: November 23, 2017

7.8K

Análisis de los resultados basados en el tratamiento para el Dermatofibrosarcoma Protuberans: un estudio en un solo

Timothy J Freeman1, Pooja Shet2, Basia M Michalski-McNeely3

  • 1Washington University School of Medicine, St. Louis, Missouri.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
|September 3, 2025
PubMed
Resumen

No abstract available in PubMed .

Más Videos Relacionados

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.4K
Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

8.0K

Videos de Experimentos Relacionados

Last Updated: Jun 14, 2026

Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata
07:58

Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata

Published on: November 23, 2017

7.8K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.4K
Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

8.0K

Videos de Conceptos Relacionados

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Differentiating superficial fungal infection from eczema using a heated dynamic-headspace skin VOC sampler: a hypothesis.

Frontiers in medicine·2026

Extramammary Paget Disease: A Single-Center, Clinical Analysis.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026

Trends in Pediatric Representation Within Skin of Color Dermatology Literature: A Decade-Long Analysis.

Pediatric dermatology·2026

Patient Satisfaction With Outcomes of Mohs Micrographic Surgery: A Prospective Cohort Study Using the Oxford Skin Cancer Treatment Scale.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026

Dermatologic Oncology: The Past 50 Years.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2025

Medical Spa Legislation, Regulations, and Guidelines in the United States.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2025

Increasing Use of Tumor Necrosis Factor-Alpha Inhibitors Among Medicare Beneficiaries Despite Known Increased Risk of Nonmelanoma Skin Cancer.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026

Ablative Fractional CO2 Laser Resurfacing for Atrophic Acne Scars During and After Oral Isotretinoin: A Single-Center Retrospective Cohort Study in Fitzpatrick III-VI Patients.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026

Safety Considerations and Complications With Radiofrequency Microneedling: A Cross-Sectional Analysis of the US FDA MAUDE Database.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026

No Increased Mortality Hazard Among High-Dose Topical and Oral Isotretinoin Users: Revisiting the VATTC.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026

Clinical Risk and Regulatory Oversight for Office-Based Cosmetic Procedures: A State-By-State Analysis.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026

Poly-l-Lactic Acid Safety Over the Past 5-years: Analysis of US Food and Drug Administration Database Reports (2020-2025).

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026

A Novel 7 Sialylation-Related LncRNA Signature as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma.

Current medicinal chemistry·2026

Prediction of meningioma shrinkage after cyproterone acetate cessation.

Neuro-oncology advances·2026

Risk of colorectal cancer incidence and mortality after removals of polyps: a cohort study using the UK Biobank.

Annals of gastroenterology·2026

<i>In vivo</i> assessment of melanoma based on photoacoustic absorption and viscoelasticity imaging.

Biomedical optics express·2026

High-sensitivity Raman spectroscopy for prostate cancer detection and tissue extraction guidance.

Biomedical optics express·2026

Development and validation of a multimodal interpretable machine learning model for the identification of osteoporosis in patients with type 2 diabetes mellitus: a multicenter retrospective study.

Frontiers in endocrinology·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas
Jove
Visualize
Contáctanos